Nulecit

— THERAPEUTIC CATEGORIES —
  • Anemias

Nulecit Generic Name & Formulations

General Description

Iron (as sodium ferric gluconate complex in sucrose) 12.5mg/mL; soln for IV inj or infusion; contains benzyl alcohol.

Pharmacological Class

Hematinic.

How Supplied

Vials (5mL)—10

Manufacturer

Nulecit Indications

Indications

Iron deficiency anemia in patients on chronic hemodialysis receiving epoetin therapy.

Nulecit Dosage and Administration

Adult

Give by IV infusion (diluted) or slow IV inj (undiluted). 125mg infused over 1 hour or by slow IV inj (at a rate of up to 12.5mg/min). Minimum cumulative dose: 1g given over 8 sequential dialysis sessions; usual max: 125mg/dose.

Children

<6yrs: not recommended. Give by IV infusion (diluted) over 1 hour. ≥6yrs: 1.5mg/kg per dose at 8 sequential dialysis sessions; max: 125mg/dose.

Nulecit Contraindications

Contraindications

Anemias not caused by iron deficiency. Iron overload.

Nulecit Boxed Warnings

Not Applicable

Nulecit Warnings/Precautions

Warnings/Precautions

Hemoglobinopathies. Refractory anemias. Avoid in neonates. Pregnancy (Cat. B). Nursing mothers.

Nulecit Pharmacokinetics

See Literature

Nulecit Interactions

Interactions

May reduce absorption of concomitant oral iron preparations.

Nulecit Adverse Reactions

Adverse Reactions

Hypotension, hypertension, GI upset, chest pain, back pain, abdominal pain, pruritus, inj site reaction, cramps, headache, dizziness, syncope, fatigue, fever, dyspnea, tachycardia; rare: hypersensitivity reactions.

Nulecit Clinical Trials

See Literature

Nulecit Note

Not Applicable

Nulecit Patient Counseling

See Literature